Reduced Intensity Haplo Plus Single Cord Transplant Compared To Double Cord Transplant: Improved Engraftment And Survival Free Of Progression And GVHD (GRFS)

Haematologica February 2016 : Doi:10.3324/haematol.2015.138594

 

Abstract

Umbilical cord blood stem cell transplants are commonly used in adults lacking HLA-identical donors. Delays in hematopoietic recovery contribute to mortality and morbidity. To hasten recovery we used co-infusion of progenitor cells from a partially matched related donor and an UCB (haplo-cord transplant).

Read more

Sibling umbilical cord blood stem cells conveyed warmth of life

Elham, a 12-year-old girl from Isfahan, Iran, was diagnosed with the ALL form of leukemia in 2014. Since then she underwent chemotherapy three times as the main treatment method, but it turned out to be all in vain. She was cured by a stem cell transplant from her baby sister’s umbilical cord blood.

 

Read more

Stem Cell Therapy Improves Function, Extends Survival in Children with Krabbe Disease

Umbilical cord blood transplantation can improve neurologic outcomes in the short term if performed before symptoms appear, but long-term outcomes are unknown.
The findings demonstrate that "HSCT performed before the onset of severe symptoms delays disease progression and improves both length and quality of life" over the long term, the study authors, led by Matthew D. Wright, MD, of the program for the study of neurodevelopment in rare disorders at the University of Pittsburgh in Pittsburgh, PA, wrote.

Read more

Stem cell therapy plan for placentas

Julie Robotham, Medical Editor

STEM cells would be harvested from the placentas and umbilical cords of newborn babies, under a plan Australian researchers say could yield therapies for conditions ranging from arthritis to burns. But other doctors say the proposed service - costing families about $5000 - preys on the fears of new parents and has insufficient scientific backing...

Read more

THE BENEFITS OF THE STEM CELLS IN YOUR BABY’S UMBILICAL CORD

The umbilical cord is a connection between the fetus and the placenta. The components of the cord are umbilical arteries, vein, and jelly. The blood in the umbilical cord at birth is usually rich in stem cells. The stem cells are referred to as hematopoietic stem cells. These stem cells are capable of growing into different kind of blood cells; erythrocytes, leucocytes, and platelets. The umbilical stem cells have been useful in the treatment of many hematological and non- hematological diseases. They have also been very useful to researchers. The procedure of collecting the blood does not inconvenience the mother or the newborn in any way. However, they are extracted with the permission of the presence of the baby. In fact, this same blood is normally discarded as waste after delivery.

Read more

The Components of Blood and their Importance

Blood is a specialized fluid in your body that has four main components, each with a different function: plasma, red blood cells, white blood cells, and platelets. Watch this video to learn more about how these components work.

Read more

Therapeutic Potential of Cord Blood Stem Cells Enhanced With New Technology

Science Daily

A CD26 Inhibitor increases the efficiency and responsiveness of umbilical cord blood for bone marrow transplants and may improve care for blood cancer patients according to research from Rush University Medical Center being presented at the 6th Annual International Umbilical Cord Blood Transplantation Symposium, June 6-7 in Los Angeles...

Read more

Twins and Cord Blood Banking

The reassuring conclusion of the Cryo-Cell study is that cord blood units collected from multiple births have sufficient numbers of stem cells to treat children for cerebral palsy and other conditions identified in infancy, under current dosing guidelines. 

Read more

Umbilical cord blood transplantation: the first 25 years and beyond

  • Karen K. Ballen1,
  • Eliane Gluckman2, and
  • Hal E. Broxmeyer3

+ Author Affiliations

  • 1Massachusetts General Hospital Cancer Center, Boston, MA;
  • 2Eurocord Hospital Saint Louis, APHP, University Paris-Diderot, Paris, France; and
  • 3Indiana University School of Medicine, Indianapolis, IN

 

Abstract

 

Umbilical cord blood is an alternative hematopoietic stem cell source for patients with hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation. Initially, umbilical cord blood transplantation was limited to children, given the low cell dose infused. Both related and unrelated cord blood transplants have been performed with high rates of success for a variety of hematologic disorders and metabolic storage diseases in the pediatric setting.

Read more